← Back to Search

Behavioral Intervention

Cognitive Enhancement Therapy vs. Social Skills Training for Mental Illness

N/A
Recruiting
Led By Matcheri S Keshavan, MD
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 to 65
DSM-5 diagnosis of schizophrenia or schizoaffective or schizophreniform disorder (confirmed via the MINI diagnostic interview)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measurement at 0, 6, 12, 18, 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is comparing two different treatments to see which is more effective in improving community functioning.

Who is the study for?
This trial is for adults aged 18 to 65 with a diagnosis of schizophrenia or related disorders, who have an IQ over 70. It's not suitable for those with brain syndromes, intellectual disabilities, or recent participation in the therapies being tested.
What is being tested?
The study compares Cognitive Enhancement Therapy (CET) and Social Skills Training (SST), both known to improve community functioning in people with serious mental illness. Mental health centers are randomly chosen to use either CET or SST.
What are the potential side effects?
Since CET and SST are non-medical treatments focusing on cognitive skills and social abilities, they may cause fatigue or emotional distress but do not have typical drug-related side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I have been diagnosed with schizophrenia or a related disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measurement at 0, 6, 12, 18, 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and measurement at 0, 6, 12, 18, 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Heinrich Quality of Life Scale
Change in Social Adjustment Scale II
Change in Social Skills Performance Assessment
Secondary study objectives
Change in Auditory Verbal Learning Test
Change in List Sorting Working Memory
Change in Managing Emotions
+8 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive Enhancement TherapyExperimental Treatment1 Intervention
CET is a comprehensive manualized cognitive remediation program designed to maximize gains in social functioning by integrating computer-based training to enhance neurocognition with group-based exercises to improve social cognition.
Group II: Social Skills TrainingActive Control1 Intervention
The HOPES social rehabilitation program uses the principles of SST (modeling, role playing, positive and corrective feedback, homework assignments, in vivo skills practice), designed to improve both psychosocial functioning and preventive health..
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Enhancement Therapy
2012
N/A
~160

Find a Location

Who is running the clinical trial?

Patient-Centered Outcomes Research InstituteOTHER
580 Previous Clinical Trials
27,104,881 Total Patients Enrolled
5 Trials studying Schizophrenia
86,178 Patients Enrolled for Schizophrenia
Beth Israel Deaconess Medical CenterLead Sponsor
861 Previous Clinical Trials
12,932,448 Total Patients Enrolled
23 Trials studying Schizophrenia
2,213 Patients Enrolled for Schizophrenia
Matcheri S Keshavan, MDPrincipal InvestigatorBeth Israel Deaconess Medical Center
1 Previous Clinical Trials
67 Total Patients Enrolled
1 Trials studying Schizophrenia
67 Patients Enrolled for Schizophrenia
Russell K Schutt, PhDPrincipal InvestigatorBeth Israel Deaconess Medical Center

Media Library

Cognitive Enhancement Therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04321759 — N/A
Schizophrenia Research Study Groups: Cognitive Enhancement Therapy, Social Skills Training
Schizophrenia Clinical Trial 2023: Cognitive Enhancement Therapy Highlights & Side Effects. Trial Name: NCT04321759 — N/A
Cognitive Enhancement Therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04321759 — N/A
~89 spots leftby Jan 2026